Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from cinnamomum
Reexamination Certificate
2008-06-03
2008-06-03
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from cinnamomum
C424S758000, C424S764000, C424S738000
Reexamination Certificate
active
07381435
ABSTRACT:
By administering a composition comprising pumpkin seed, safflower, plantain and honeysuckle, subjective symptoms (for example, general malaise and abdominal swelling) of a patient with chronic hepatitis C can be eliminated and, moreover, objective symptoms diagnosed by a medical doctor (for example, liver enlargement and palm erythema) can be relieved or eliminated. From 1 to 3 months after the administration of the composition, a significant decrease in hepatitis C virus RNA level is gradually observed. Therefore, the above composition is useful at least as a composition for treating chronic hepatitis C. In particular, it is advantageous in treating a chronic hepatitis C patient showing a high chronic hepatitis C virus RNA level.
REFERENCES:
patent: 445697 (1891-02-01), Grout et al.
patent: 4421746 (1983-12-01), Kojima et al.
patent: 4456597 (1984-06-01), Kojima et al.
patent: 4469685 (1984-09-01), Kojima et al.
patent: 5837257 (1998-11-01), Tsai et al.
patent: 5882672 (1999-03-01), Kojima et al.
patent: 5929038 (1999-07-01), Chang
patent: 1077384 (1993-10-01), None
patent: 1252292 (2000-05-01), None
patent: 10-279491 (1998-10-01), None
patent: 11-116498 (1999-04-01), None
patent: 2000-262226 (2000-09-01), None
patent: 2000-281584 (2000-10-01), None
Hwang, Shinn-Jang, “Heapatitis C virus infection: an overview,” Dec. 2001, J Microbiol Immunol Infect, 34(4): 227-234.
Nishibe, et al., “Bioactive Components of Plantago Herb”, Foods Food Ingredients J. Jpn., FFI Journal No. 166, pp. 43-49, (1995).
Chang, “Liver-Protective Activities of Aucubin Derived from Traditional Oriental Medicine”, Research Communications in Molecular Pathology and Pharmocology, vol. 102, No. 2, pp. 189-204, (1998).
Imaoka, et al., “Chinese herbal medicines capable of IgE antibody suppression and IFN induction”, J. Traditional Medicines, vol. 12, No. 3, 262(3.), pp. 257-263, (1995).
Seeff, et al., “Complementary and Alternative Medicine in Chronic Liver Disease”, Hepatology, vol. 34, No. 3, pp. 595-603, (2001).
Hussein, et al., “Inhibitory Effects of Sudanese Medicinal Plant Extracts on Hepatitis C Virus (HCV) Protease”, Phytotherapy Research, vol. 14, No. 7, pp. 510-516, (2000).
Kato, N., Hepatitis C Virus, Industrial Publishing & Consulting, Inc., Tokyo, 2000, pp. 167-182.
Kumagai, Naoki, Hepatitis C, Mainichi Life, Sep. 2002 issue, p. 23, The Yomiuri Shimbun, 2002.
Kato, N., Hepatitis C Virus, Industrial Publishing & Consulting, Inc., Tokyo, 2000, p. 188-201.
Hussein et al., Inhibitory Effects of Sudanese Medicinal Plant Extracts on Hepatitis C Virus (HCV) Protease, Phytotherapy Research (2000) 14, 510-516.
Lin et al., Medicinal Plants Used for the Treatment of Hepatitis in Taiwan, American Journal of Chinese Medicine, (1990) vol. XVIII. Nos. 1-2, pp. 35-43.
1995 report of the Anti-hepatitis A and B Study Group of the Ministry of Health and Welfare.
Sato et al., The N55A Region and the Prediction of Interferon Effect, in Progress of Medicinal Science, separate volume, “Search for the Onset and Progress Mechanism of Liver Disorders,” issued on Feb. 5, 1999.
Yatsuhashi et al., HCV-RNA Levels and IFN Treatment, in Progress of Medicinal Science, separate volume, “Search for the Onset and Progress Mechanism of Liver Disorders,” issued on Feb. 5, 1999.
Oshita et al., Retreatment with Interferon in Patients with Hepatitis C, in Progress of Medicinal Science, separate volume, “Search for the Onset and Progress Mechanism of Liver Disorders,” issued on Feb. 5, 1999.
Ikenoue et al.,, Interferon Therapy for Type C Chronic Hepatitis and Cirrhosis: Does Interferon Reduce the Incidence of Hepatocellular Carcinoma? in Progress of Medicinal Science, separate volume, “Search for the Onset and Progress Mechanism of Liver Disorders,” issued on Feb. 5, 1999.
Suzuki et al., A Novel Interferon for the Treatment of Hepatitis C, Kan Tan Sui 43, (2), pp. 281-288, 2001.
Kaneko Shuichi
Yoshida Satoshi
Anderson Heather L
Finnegan Henderson Farabow Garrett & Dunner LLP
Original Image Co., Ltd.
Tate Christopher R.
LandOfFree
Composition for treating hepatitis C does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for treating hepatitis C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating hepatitis C will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2811875